Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Toujeo (insulin glargine) and Apidra (insulin glulisine) are both insulins used to manage both Type 1 and Type 2 diabetes, but they have some key differences. Toujeo is a long-acting insulin that provides consistent blood sugar control for up to 36 hours and is typically injected once a day. In contrast, Apidra is a rapid-acting insulin that starts working within 15 minutes and is usually taken before or right after meals to control blood sugar spikes. Neither medication is available in a generic form yet, but Apidra is comes in both vials and prefilled pens and can also be used in an insulin pump. Apidra can be mixed with NPH insulin, but Toujeo cannot be mixed with any other insulins. Both medications can cause low blood sugar and weight gain, but Apidra has a higher risk of causing low blood sugar due to its rapid action. Additionally, Toujeo is suitable for children as young as 6 years old, whereas Apidra can be used in children starting at age 4.
Toujeo (insulin glargine)
Apidra (insulin glulisine)
Toujeo (insulin glargine)
Apidra (insulin glulisine)
Summary of Toujeo vs. Apidra
Summary for Insulin
Prescription only
Toujeo SoloStar and Toujeo Max SoloStar are a pair of brand names for insulin glargine. This medication is a long-acting insulin that's used for diabetes in adults and children. It's a more concentrated version of insulin glargine containing 300 units/mL. It comes as prefilled pens that you use for once-daily injections under the skin. Side effects include common cold symptoms and low blood sugar.
Summary for Insulin
Prescription only
Insulin glulisine is a rapid-acting insulin that's available as a vial (Apidra) and a pre-filled pen (Apidra Solostar). It's used to control blood sugar from meals for people with either Type 1 diabetes (T1D) or Type 2 diabetes (T2D). Apidra (insulin glulisine) is given under the skin as either a quick injection or continuously through an insulin pump. It can also be given as an injection through the veins (IV) for people in the hospital. Side effects include low blood sugar (hypoglycemia) and common cold symptoms.